Catecholamine-induced lipolysis in obesity

被引:136
作者
Arner P. [1 ]
机构
[1] Department of Medicine, Karolinska Institute at Huddinge University Hospital, CME, Huddinge
关键词
Adipose tissue; Adrenergic receptors; Diet; Exercise; Fat acids; Fat cells; Genes; Insulin;
D O I
10.1038/sj.ijo.0800789
中图分类号
学科分类号
摘要
Catecholamines are the only hormones with pronounced lipolytic action in man. A number of in vivo and in vitro studies suggest that there is lipolytic resistance to catecholamines in subcutaneous adipose tissue, which is the major fat depot in obese subjects. This is due to multiple alterations in catecholamine signal transduction, involving decreased expression and function of β2-adrenoceptors, increased function of α2-adrenoceptors and decreased ability of cyclic monophosphate (AMP) to stimulate hormone sensitive lipase. A sedentary life-style, which usually characterizes obesity, may contribute to the catecholamine resistance. However, hereditary/genetic factors may also be involved. Recently, decreased expression and function of hormone sensitive lipase has been found in subcutaneous adipocytes of non-obese subjects with heredity for obesity. In addition, polymorphisms in the genes for β2-adrenoceptors, β3-adrenoceptors and hormone sensitive lipase, associate with obesity. On the other hand, catecholamine-induced lipolysis in visceral adipose tissue is increased in obesity due to increased function of β3-adrenoceptors (major finding), decreased function of α2-adrenoceptors and increased ability of cyclic AMP to stimulate lipolysis. When the findings in different adipose regions are considered together, it appears that there is a re-distribution of lipolysis and thereby fatty acid mobilization in obesity, favouring the visceral fat depot. This leads to an increase in the circulating fatty acid levels in the portal vein, which connects visceral fat with the liver. As a consequence, the liver function may be altered leading to hyperinsulinemia, hyperglycemia and dyslipidemia, which usually accompany the obese state. © 1999 Stockton Press. All rights reserved.
引用
收藏
页码:10 / 13
页数:3
相关论文
共 18 条
[1]  
Ramsay T.G., Fat cells, Endocrinol Metab Clin North Am, 25, pp. 847-870, (1996)
[2]  
Arner P., Regulation of lipolysis in fat cells, Diabetes Rev, 4, pp. 450-463, (1996)
[3]  
Jensen M.D., Lipolysis: Contribution from regional fat, Annu Revnutr, 17, pp. 127-139, (1997)
[4]  
Leibel R.L., Eddens N.K., Fried S.K., Physiological basis for the control of body fat distribution in humans, Annu Rev Nutr, 9, pp. 417-443, (1989)
[5]  
Arner P., Differences in lipolysis between human subcutaneous and omental adipose tissue, Annu Med, 27, pp. 437-438, (1995)
[6]  
Hoffstedt J., Arner P., Heller G., Lonnqvist F., Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men, J Lipid Res, 38, pp. 795-804, (1997)
[7]  
Bougneres P., Le Stunff C., Pecqueur C., Pinglier E., Adnot P., Ricquier d. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity, J Clin Invest, 99, pp. 2568-2573, (1997)
[8]  
Lonnqvist F., Nyberg B., Wahrenberg H., Arner P., Catechola-mines-induced lipolysis in adipose tissue of elderly, J Clin Invest, 85, pp. 1614-1621, (1990)
[9]  
Kissebah A.H., Intra-abdominal fat: Is it a major factor in developing diabetes and coronary artery disease?, Diabetes Res Clin Pract, 30, pp. 25-30, (1996)
[10]  
Reynisdottir S., Langin D., Carlstrom K., Holm C., Rossner S., Arner P., Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity, Clin Sci, 89, pp. 421-429, (1995)